Krankenhaus Nordwest | Thoracic Oncology Clinic

Research site
Steinbacher Hohl 2-26, Frankfurt am Main, Hesse, Germany
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


3 of 13
Status: Active
Trial type: Interventional
Funder type: Industry

A Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR and Anti-c-MET Bispecific Antibody, in Patients With Advanced NSCLC and Other Solid Tumors

A phase 1/2 open-label multicenter study will be performed with an initial dose escalation part to determine the MTD and/or the RP2D of MCLA-129 as m...

Non-Small Cell Lung Cancer Metastatic
Gastric Cancer
Drug: MCLA-129
Drug: Osimertinib

The purpose of this clinical phase 3 randomized trial is to compare two different dosing schedules of Docetaxel in combination with ADT and Darolutam...

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Drug: Docetaxel
Drug: Standard ADT (androgen deprivation therapy)

This is a Phase III, global, multicenter, open-label, randomized study to compare the efficacy and safety of 16 cycles (1 cycle duration=21 days) of...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Gemcitabine
Drug: Pemetrexed

Trial conditions

Non-Small-Cell Lung Carc... (3 trials)
Adenocarcinoma (2 trials)
Carcinoma (2 trials)
Stomach Cancer (2 trials)
Biliary Tract Cancer (1 trial)
Cholangiocarcinoma (1 trial)
Esophageal Squamous Cell... (1 trial)
Hepatocellular Carcinoma (1 trial)
Hypersensitivity (1 trial)
Klatskin Tumor (1 trial)

And 12 more

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems